A recombinant protein therapy is produced through recombinant DNA technology, which involves inserting the DNA encoding the protein into bacterial or mammalian cells, expressing the protein in ...

Eli Lilly and Company is leading a global effort to protect wildlife by shifting away from horseshoe crab blood and using a ...

Dr. Brandicourt is a distinguished executive in the biopharmaceutical industry. He is currently a Senior Advisor at ...

Introduction: The DNA of a Biotech BoomThe global plasmid DNA manufacturing market is entering a transformative era, driven by revolutionary advancements in gene therapy, cancer immunotherapy, DNA ...

For the second-generation HBV vaccine, the expression of recombinant hepatitis B surface antigen (HBsAg) protein is developed in yeast or mammalian cells that contain the surface gene of the virus.

According to the US' CDC, the ongoing clade II 2022 mpox outbreak has been responsible for over 100,000 infections in 122 countries to date worldwide.

Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...

DNA (deoxyribonucleic acid) is the nucleic acid polymer that forms the genetic code for a cell or virus ... bind both the recombinant protein and bacteria, demonstrating potential for enhanced ...

For many years, the potential of immunoglobulin M (IgM) antibodies was not fully understood because of characteristics different to the well-known immunoglobulin G type like low target affinity, cross ...

The threat is called mirror bacteria ... cell design. Their aim is to understand the living world by attempting to recreate it from a minimum of constituents – just a few genes and proteins.

A research team has uncovered a previously unknown type of immune signaling molecule—a novel compound combining histidine and ...